Innocon, a leader in solutions and innovation for the aquaculture industry, has made significant progress in the project that frames the development of oral vaccines for salmon farming, with a focus. ..
Innocon, a leader in solutions and innovation for the aquaculture industry, has made significant progress in the project that frames the development of oral vaccines for salmon farming, with special attention to prevention of Salmon Rickettsial Septicemia (SRS). This initiative will not only improve the health of salmon, but also reduce the economic losses associated with this disease, opening new possibilities for more efficient and sustainable production.
SRS is a bacterial disease that has posed a significant challenge to the salmon industry for many years. This affects fish in their marine culture stage, causing large losses and concerns about the use of antibiotics and the resulting impact on the environment. The need to address this disease effectively is essential for the long-term sustainability of the aquaculture industry in a sustainable manner.
The Innocon Oral Vaccine Project
Innocon’s Microbiology and Molecular Biology team is at the forefront of oral vaccine research and development for aquaculture. “Our current project focuses on the creation of an oral vaccine against SRS, but we also design that this technology can serve as a vehicle to prevent other diseases in the future. This broad vision seeks to solving many health challenges efficiently and sustainably,” commented Milica Sevo, Head of Microbiology R&D at Innocon.
For his part, Jorge Sepúlveda, head of the company’s R&D Molecular Biology, commented that: “We believe in the future of salmon farming and the potential that our oral vaccines can provide to create a more efficient industry with in relation to its effects. the preventive health of the fish, the reduction of the use of antibiotics and the care of the waters where they are farmed. “We will continue to work tirelessly to make this vision a reality and keep Chile at the forefront of innovation in salmon production and farming.”
The vaccine, which is currently in a platform validation stage to prevent SRS and other diseases, will allow the national salmon industry to be promoted more competitively at the global level. With the commitment to have this market-leading solution to benefit the science and development of aquaculture. “The tests carried out in recent months confirm the potential of salmon farming technology, which helps not only the industry itself, but also the preservation of the aquatic ecosystem and the promotion of sustainable farming methods,” Sepúlveda concluded. .
